ReAlta Life Sciences, Inc. appoints Ellen Lubman as Chief Business Officer to lead business development, capital formation, and corporate strategy. With 25 years of experience in biopharmaceutical companies, including Werewolf Therapeutics, she brings a strong track record in strategic, transactional, and operational roles.

David Marek, ReAlta’s CEO, praises Ellen Lubman’s expertise in building partnerships, raising capital, and developing successful corporate strategies for biotech and pharmaceutical companies. He highlights her arrival at a crucial time as all three clinical programs are set to report results this year.

Ellen Lubman, the newly appointed Chief Business Officer at ReAlta, holds an M.B.A. from Stanford Graduate School of Business and a B.A. in Biology from Rutgers College. Her extensive experience and educational background position her well to drive the company’s growth and success.

Read more at Yahoo Finance: ReAlta Life Sciences Appoints Ellen Lubman as Chief Business Officer